XML 40 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity (Tables)
12 Months Ended
May 31, 2014
Equity [Abstract]  
Schedule summarizes stock option activity
The following schedule summarizes our stock option activity as of and for the years ended May 31, 2014, May 31, 2013 and May 31, 2012:
 
 
2014
 
2013
 
2012
 
Shares
 
Weighted-
average
exercise
price
 
Weighted
average
remaining
contractual
life
 
Aggregate
intrinsic
value (in
thousands)
 
Shares
 
Weighted-
average
exercise
price
 
Shares
 
Weighted-
average
exercise
price
Outstanding at beginning of year
2,768,928

 
$
14.84

 
 
 
 
 
2,985,192

 
$
15.69

 
2,680,390

 
$
15.96

Granted
391,175

 
$
13.01

 
 
 
 
 
406,700

 
$
11.40

 
1,434,000

 
$
13.70

Exercised
(105,676
)
 
$
15.38

 
 
 
 
 
(16,835
)
 
$
11.15

 
(193,684
)
 
$
14.22

Forfeited
(278,646
)
 
$
17.45

 
 
 
 
 
(589,787
)
 
$
17.45

 
(917,126
)
 
$
14.22

Expired
(102,030
)
 
$
15.69

 
 
 
 
 
(16,342
)
 
$
15.69

 
(18,388
)
 
$
24.44

Outstanding at end of year
2,673,751

 
$
14.82

 
4.56
 
$
17,540

 
2,768,928

 
$
14.84

 
2,985,192

 
$
15.69

Options exercisable at year-end
1,675,790

 
$
16.12

 
4.54
 
$
12,906

 
1,601,028

 
$
16.12

 
1,678,559

 
$
17.01

Options expected to vest in future periods
845,256

 
$
13.31

 
5.06
 
$
3,986

 
1,069,119

 
$
13.31

 
1,075,473

 
$
14.19

Summary of weighted average fair value of options granted
Weighted average fair value of options granted during the fiscal years ended May 31, is as follows:
 
 
2014
 
2013
 
2012
Weighted-average fair value of options granted during the year
$
4.10

 
$
4.19

 
$
5.62

Schedule of weighted-average fair value assumptions
The fair value of the options granted under the 1997 and 2004 Plans was estimated at the date of grant using the Black-Scholes option-pricing model assuming no expected dividends and the following weighted-average assumptions:
 
 
2014
 
2013
 
2012
Expected stock price volatility
34.40
%
 
43.91
%
 
49.06
%
Risk-free interest rate
1.44
%
 
0.62
%
 
0.70
%
Expected life of options
4.74

 
4.62 years

 
4.59 years

Summary of options outstanding
The following information applies to options outstanding at May 31, 2013:
 
Range of exercise prices
Number
outstanding
 
Weighted-
average
remaining
life in
years
 
Weighted-
average
exercise
price
 
Number
Exercisable
 
Weighted-
average
exercise
price
$  6.52 - $11.93
463,965

 
5.64
 
$
11.37

 
65,832

 
$
10.61

$12.06 - $12.97
343,161

 
4.86
 
12.41

 
155,661

 
12.44

$13.18 - $13.85
432,426

 
3.38
 
13.35

 
321,348

 
13.36

$13.92 - $14.31
430,000

 
4.21
 
13.95

 
228,750

 
13.97

$14.48 - $15.57
202,880

 
1.09
 
15.25

 
202,880

 
15.25

$15.75 - $16.58
376,196

 
3.39
 
16.06

 
276,196

 
16.03

$16.75 - $19.94
267,522

 
1.06
 
18.19

 
267,522

 
18.16

$20.06 - $31.33
157,601

 
1.26
 
23.05

 
157,601

 
13.81

 
2,673,751

 
4.56
 
$
14.84

 
1,675,790

 
$
16.12

Share based compensation arrangement by share based payment award nonvested shares and weighted average grant date fair value
 
Non-Vested Stock
Award Units
 
Weighted Average
Grant-Date Fair  Value
Balance as of May 31, 2013
482,644

 
$
12.14

Granted
473,824

 
13.37

Cancelled
(109,634
)
 
12.48

Vested
(148,946
)
 
12.62

Balance as of May 31, 2014
697,888

 
13.02

Summary of future expense for awards outstanding
Under the provisions of authoritative guidance on share based payment awards, we expect to recognize the following future expense for awards outstanding as of May 31, 2014 ($ in thousands):
 
 
Unrecognized
Compensation
Cost
 
Weighted Average
Remaining Vesting
Period (in years)
Stock options
$
3,382

 
2.13
Non-vested stock awards
5,625

 
2.37
 
$
9,007

 
2.28
Summary of stock-based compensation in accordance with authoritative guidance on share based payment awards
The following table summarizes stock-based compensation in accordance with authoritative guidance on share based payment awards for the years ended May 31, 2014, May 31, 2013 and May 31, 2012, which was allocated as follows:
 
 
May 31,
2014
 
May 31,
2013
 
May 31,
2012
 
(In thousands)
Cost of sales
$
232

 
$
271

 
$
268

Research and development
483

 
399

 
738

Sales and marketing
1,672

 
1,610

 
1,340

General and administrative
3,035

 
2,329

 
1,744

Stock based compensation expense included in operating expenses
5,190

 
4,338

 
3,822

Total stock based compensation
5,422

 
4,609

 
4,090

Tax benefit
1,657

 
1,540

 
1,386

Stock based compensation expense, net of tax
$
3,765

 
$
3,069

 
$
2,704